Pd-Catalyzed Copolymerization of Ethylene and R-Olefins
overlapping with BAr′4-signal, 2H; Ho of C6H3(CF3)2), 7.48-7.33 (m,
J. Am. Chem. Soc., Vol. 120, No. 5, 1998 897
0.66 (pentet, 2, J ) 5.76, PdCH2CH2CH2C(O)); 13C NMR (CD2Cl2,
100 MHz, room temperature) δ 183.4 (C(O)), 178.7 and 171.6 (NdC-
C′dN), 140.8 and 140.5 (Ar, Ar′: Cipso), 138.6 and 138.0 (Ar, Ar′:
Co), 129.3 and 128.3 (Ar, Ar′: Cp), 124.9 and 124.4 (Ar, Ar′: Cm),
54.9 (OMe), 35.8 and 30.3 (PdCH2CH2CH2C(O)), 29.5 and 29.2
(CHMe2, C′HMe2), 23.7 (PdCH2CH2CH2C(O)), 23.91, 23.86, 23.20 and
23.14 (CHMeMe′, C′HMeMe′), 21.6 and 19.9 (NdC(Me)-C′(Me)dN);
IR (CH2Cl2) 1643 cm-1 [ν(C(O))]. 7′b: 1H NMR (CD2Cl2, 400 MHz,
room temperature) δ 3.47 (s, 3, OMe), 2.54 (m, 1, CHMeC(O)), 2.19
and 2.18 (s, 3 each, NdC(Me)-C′(Me)dN), 1.02 (d, 3, J ) 7.23,
CHMeC(O)); 13C NMR (CD2Cl2, 100 MHz, room temperature) δ 194.5
(C(O)), 179.2 and 172.2 (NdC-C′dN), 55.6 (OMe), 44.3 (CHMeC-
(O)), 28.4 (PdCH2), 21.2 and 19.6 (NdC(Me)-C′(Me)dN), 18.1
(CHMeC(O)). 7b: 1H NMR (CD2Cl2, 400 MHz, room temperature) δ
0.26 (d, 3, PdCHMe). Anal. Calcd for (C65H61BF24N2O2Pd): C, 52.92;
H, 4.17; N, 1.90. Found: C, 52.91; H, 4.09; N, 1.68.
i
6H; C6H3 Pr2), 2.98 and 2.89 (septet, J ) 7 Hz, 2H each, CHMe2 and
C′HMe2), 2.28 and 2.26 (s, 3H each, NdC(Me)-C′(Me)dN), 1.36,
1.35, 1.26 and 1.23 (d, J ) 7, 6H each; CHMeMe′ and C′HMeMe′),
0.70 (s, 3H; PdMe). Anal. Calcd for (C70H58BF30N3Pd): C, 51.63;
H, 3.59; N, 2.58. Found: C, 51.59; H, 3.64; N, 2.51.
[(ArNdC(Me)-C(Me)dNAr)Pd(CH2)3C(O)OMe](BAr′4) (2d; Ar
t 2,6-Me2C6H3). Diethyl ether (3 mL) was added to a mixture of
0.1861 g of [(N∧N)PdMeCl] (0.414 mmol) and 0.3700 g of NaBAr′4
(0.417 mmol). The yellow suspension was stirred for 20 min, and then
methylene chloride (10 mL) was added, followed by 50 µL MA (0.6
mmol). After being stirred for 1.5 h, the resulting brown mixture was
concentrated in vacuo to ca. 3 mL. Addition of pentane (20 mL) yielded
a brown precipitate. The supernatant was decanted, and the precipitate
was washed with pentane and dried in vacuo briefly. The solid was
redissolved in methylene chloride (3 mL), and cannula filtration yielded
a clear bright red solution. Removal of solvent and drying in vacuo
gave 0.49 g of orange powder (87%), which consisted of a mixture of
2d (89%), 7′d (6%), and 7d (5%). 1H NMR (CDCl3, 250 MHz) 2d:
δ 7.16 and 7.07 (s, 3H each; C6H3Me2 and C′6H3Me2), 3.03 (s, 3H;
OMe), 2.34 (t, J ) 6 Hz, 2H; CH2C(O)), 2.14 and 2.12 (s, 6H each;
C6H3Me2 and C′6H3Me2), 2.09 and 2.04 (s, 3H each; NdC(Me)-
C′(Me)dN), 1.22 (t, J ) 6 Hz, 2H; PdCH2), 0.63 (pentet, J ) 6 Hz,
2H; PdCH2CH2CH2C(O)). IR (CH2Cl2) 1643 cm-1 (CdO). 7d: δ
3.71 (s, 3H; OMe), 0.23 (d, J ) 7 Hz, 3H; PdCHMe). 7′d: δ 3.47 (s;
OMe). Anal. Calcd for (C57H45BF24N2O2Pd): C, 50.22; H, 3.33; N,
2.05. Found: C, 50.29; H, 3.36; N, 2.04.
General Procedure for the Synthesis of Chelate Complexes. A
gastight microliter syringe was used to add 1.1 equiv of H2CdCHC-
(O)OMe to a mixture of 1 equiv of NaBAF and 1 equiv of
(ArNdC(R)-C(R)dNAr)PdMeCl suspended in 25 mL of Et2O. The
sides of the Schlenk flask were rinsed with an additional 25 mL of
Et2O, and the reaction mixture was stirred for 1-2 days at rt. Sodium
chloride was removed from the reaction mixture via filtration, yielding
a clear orange solution. The Et2O was removed in vacuo, and the
product was washed with hexane and dried in vacuo.
[(ArNdC(An)-C(An)dNAr)Pd(CH2)3C(O)OMe](BAr′4) (2c; Ar
t 2,6-(i-Pr)2C6H3). This complex was synthesized according to the
above general procedure using (ArNdC(An)-C(An)dNAr)PdMeCl
(744 mg, 1.13 mmol), NaBAF (1.00 g, 1.13 mmol), and MA (112 µL,
1.1 equiv). The reaction mixture was stirred for 2 days, and the product
was recrystallized from CH2Cl2 at -30 °C to give 600 mg (33.8%, 2
crops) of a mixture of 2c (85%), 7′c (8%), 7′′c (6%) {PdCH2CH2C-
(O)OMe}, and 7c(Me) (1%), according to 1H NMR spectroscopy. 2c:
1H NMR (CD2Cl2, 400 MHz, room temperature) δ 8.17 (d, 1, J )
8.37, An: Hp), 8.15 (d, 1, J ) 3.49, An′: H′p), 7.62-7.40 (m, 8, An:
Hm, An′: Hm; Ar: Hm, Hp; Ar′: H′m, H′p), 7.08 (d, 1, J ) 7.19, An:
Ho), 6.60 (d, 1, J ) 7.44, An′: H′o), 3.37 (septet, 2, J ) 6.79, CHMe2),
3.33 (septet, 2, J ) 6.86, C′HMe2), 3.23 (s, 3, OMe), 2.55 (t, 2, J )
5.93, CH2C(O)), 1.79 (t, 2, J ) 5.66, PdCH2), 1.45, 1.42, 1.13 and
1.02 (d, 6 each, J ) 6.79-6.90, CHMeMe′, C′HMeMe′), 0.80 (pentet,
2, J ) 5.82, PdCH2CH2CH2C(O)); 13C NMR (CD2Cl2, 100 MHz, room
temperature) δ 183.5 (C(O)), 175.3 and 168.7 (NdC-C′dN), 145.9
(An: quaternary C), 141.3 and 140.5 (Ar, Ar′: Cipso), 139.7 and 138.4
(Ar, Ar′: Co), 133.3 and 132.6 (An: CH), 131.9 (An: quaternary C),
129.8, 129.7, 129.6 and 128.5 (Ar, Ar′: Cp; An: CH), 126.44 and 125.8
(An: quaternary C), 126.4 and 125.6 (An: CH), 125.5 and 124.6 (Ar,
Ar′: Cm), 55.0 (OMe), 35.9 and 31.3 (PdCH2CH2CH2C(O)), 29.7 and
29.4 (CHMe2, C′HMe2), 24.1 (PdCH2CH2CH2C(O)), 24.1, 23.8, 23.32
and 23.27 (CHMeMe′, C′HMeMe′); IR (CH2Cl2) 1644 cm-1 [ν(C(O))].
7′c: 1H NMR (CD2Cl2, 400 MHz, room temperature) δ 3.64 (s, 3,
OMe), 2.70 (m, 1, CHMeC(O)); 13C NMR (CD2Cl2, 100 MHz, room
temperature) δ 192.8 (C(O)). 7′′c: 1H NMR (CD2Cl2, 400 MHz, room
temperature) δ 3.67 (s, 3, OMe), 2.46 (t, 2, J ) 6.99, CH2C(O)), 1.72
(t, 2, J ) 7.04, PdCH2). 7c: 1H NMR (CD2Cl2, 400 MHz, room
[(ArNdC(H)-C(H)dNAr)Pd(CH2)3C(O)OMe](BAr′4) (2a; Ar t
2,6-(i-Pr)2C6H3). This complex was synthesized according to the above
general procedure using (ArNdC(H)-C(H)dNAr)PdMeCl (937 mg,
1.76 mmol), NaBAF (1.56 g, 1.75 mmol), and MA (175 µL, 1.1 equiv).
The resulting orange powder (2.44 g, 96.0%) consisted of a mixture of
2a (91%), 7′a (5%), and 7a (4%), according to 1H NMR spectroscopy.
1
2a: H NMR (CD2Cl2, 400 MHz, room temperature) δ 8.31 and 8.26
(s, 1 each, NdC(H)-C′(H)dN), 7.5-7.2 (m, 6, Haryl), 3.17 (s, 3, OMe),
3.14 and 3.11 (septet, 2 each, CHMe2 and C′HMe2), 2.48 (t, 2, J )
5.8, CH2C(O)), 1.75 (t, 2, J ) 5.8, PdCH2), 1.38, 1.32, 1.25, and 1.22
(d, 6 each, J ) 6.8, CHMeMe′ and C′HMeMe′), 0.73 (pentet, 2, J )
5.8, PdCH2CH2CH2C(O)); 13C NMR (CD2Cl2, 100 MHz, room tem-
temperature)
δ
0.44 (d, 3, PdCHMe). Anal. Calcd for
(C73H61BF24N2O2Pd): C, 55.80; H, 3.91; N, 1.78. Found: C, 55.76;
H, 3.82; N, 1.62.
General Procedure for Variable Temperature NMR Experi-
ments. In a drybox under an argon atmosphere, the palladium complex
(approximately 0.01 mmol) was weighed into an NMR tube. The tube
was then capped with a septum, removed from the drybox, and cooled
to -78 °C. CD2Cl2 (0.7 µL) was then added to the NMR tube via
gastight syringe, and the septum was wrapped with Parafilm. The tube
was shaken very briefly in order to dissolve the palladium complex.
After acquiring a spectrum at low temperature, gaseous or liquid olefins
and other reagents were added to the solution at -78 °C (-100 °C in
reactions involving MA added as a CD2Cl2 solution) via gastight syringe
and were dissolved in the solution by briefly shaking the NMR tube.
perature) δ 183.9 (C(O)), 167.1 (JCH ) 181.4, NdC(H)), 160.7 (JCH
)
181.3, NdC′(H)), 142.9 and 142.4 (Ar, Ar′: Cipso), 139.7 and 138.7
(Ar, Ar′: Co), 129.8 and 129.0 (Ar, Ar′: Cp), 124.6 and 124.1 (Ar,
Ar′: Cm), 55.2 (OMe), 35.9 and 32.3 (PdCH2CH2CH2C(O)), 29.3 and
29.1 (CHMe2, C′HMe2), 23.8 (PdCH2CH2CH2C(O)), 24.5, 23.9, 23.2,
and 22.5 (CHMeMe′, C′HMeMe′); IR (CH2Cl2) 1640 cm-1 [ν(C(O))].
7′a: 13C NMR (CD2Cl2, 100 MHz, room temperature) δ 193.2 (C(O)).
Spectral data for 7a are reported below. Anal. Calcd for
(C63H57BF24N2O2Pd): C, 52.28; H, 3.97; N, 1.94. Found: C, 52.08;
H, 3.75; N, 1.61.
[(ArNdC(Me)-C(Me)dNAr)Pd(CH2)3C(O)OMe](BAr′4) (2b; Ar
t 2,6-(i-Pr)2C6H3). This complex was synthesized according to the
above general procedure using (ArNdC(Me)-C(Me)dNAr)PdMeCl
(634 mg, 1.13 mmol), NaBAF (1.00 g, 1.13 mmol), and MA (112 µL,
1.1 equiv). The reaction mixture was stirred for 2 days, and the product
was recrystallized from CH2Cl2 at -30 °C to give 956 mg of orange
crystals (57.3%, 2 crops). The crystals consisted of a mixture of 2b
(87%), 7′b (11.5%), and 7b (1.5%), according to 1H NMR spectroscopy.
2b: 1H NMR (CD2Cl2, 400 MHz, room temperature) δ 7.43-7.26 (m,
6, Haryl), 3.03 (s, 3, OMe), 2.95 (septet, 2, J ) 6.79, CHMe2), 2.93
(septet, 2, J ) 6.83, C′HMe2), 2.39 (t, 2, J ) 5.86, CH2C(O)), 2.22
and 2.20 (NdC(Me)-C′(Me)dN), 1.41 (t, 2, J ) 5.74, PdCH2), 1.37,
1.30, 1.25 and 1.21 (s, 6 each, J ) 6.80-6.94, CHMeMe′, C′HMeMe′),
1
The tube was then transferred to the cold NMR probe, and H NMR
spectra were acquired (delay times g20 s, except for MA-insertion
kinetics). The molarity of the BAr′4- counterion was calculated from
the amount of palladium complex employed and used as an internal
standard.
Methyl Acrylate Chelate Formation and Rearrangement. One
equiv of MA was added to a 0.0198 M solution of [(ArNdC(H)-
C(H)dNAr)PdMe(OEt2)]BAF in CD2Cl2 at -78 °C, and the tube was
transferred to the precooled NMR probe. After 14.25 min at -80 °C,
approximately 80% of the ether adduct had been converted to the olefin
complex 5a. Two sets of bound olefin resonances were observed in a
86:14 ratio. This observation is consistent with the existence of two